Formulation of Gastroretentive Floating Drug Delivery System of Indomethacin

被引:1
|
作者
Shukla, T. [1 ]
Pandey, S. P. [1 ]
Patil, U. K. [2 ]
机构
[1] Peoples Univ, Peoples Inst Pharm & Res Ctr, Bhopal, MP, India
[2] Dr HS Gour Cent Univ, Dept Pharmaceut Sci, Sagar, MP, India
关键词
Floating drug delivery; Floating time; HPMC; Channeling agent; SUSTAINED-RELEASE; DISSOLUTION;
D O I
10.5530/ijper.48.2.6
中图分类号
G40 [教育学];
学科分类号
040101 ; 120403 ;
摘要
Indomethacin (NASID) is used as potent anti-inflammatory drug with prompt antipyretic action, mainly used for the treatment of osteoarthritis with half-life of 4.5 hours. The basic objective of present work was to prepare floating delivery system of Indomethacin for once a day formulation using gas formation technique for prolonging the gastric residence time, so that the dosage regimen and gastric irritancy can be reduced. Indomethacin was estimated in the formulation by using UV/Visible spectrophotometer (Shimazdu UV-1700) at 321 nm. Tablets were evaluated for various parameters and it was observed that the formulation having 75 mg of Indomethacin, 34% HPMC K4M, 12% sodium bi-carbonate and 20% of lactose shows better result having 96.37% drug release within 24 hr with floating lag time of 155 seconds and floating time of 22 hr. It was also observed that as the concentration of gas generating and channeling agent increases, the chances of burst release and tablet erosion increases simultaneously. In the present study it was concluded that the floating drug delivery system with reduced floating lag time and sustained drug release of Indomethacin was obtained and could be a promising gastro-retentive drug delivery system.
引用
收藏
页码:41 / 47
页数:7
相关论文
共 50 条
  • [31] Formulation, Optimization, and In vivo Evaluation of Gastroretentive Drug Delivery System of Nifedipine for the Treatment of Preeclampsia
    Megha N. Karemore
    Jasmine G. Avari
    AAPS PharmSciTech, 20
  • [32] Formulation Optimization for Gastroretentive Drug Delivery System of Carvedilol Cocrystals Using Design of Experiment
    Gasper J. Fernandes
    Mahalaxmi Rathnanand
    Journal of Pharmaceutical Innovation, 2020, 15 : 455 - 466
  • [33] Formulation and in vitro evaluation of superporous hydrogel based gastroretentive drug delivery system of vildagliptin
    Desu, Prasanna Kumar
    Pasam, Venkateswararao
    Kotra, Vijay
    JOURNAL OF RESEARCH IN PHARMACY, 2019, 23 (05): : 873 - 885
  • [34] Formulation, Optimization, and In vivo Evaluation of Gastroretentive Drug Delivery System of Nifedipine for the Treatment of Preeclampsia
    Karemore, Megha N.
    Avari, Jasmine G.
    AAPS PHARMSCITECH, 2019, 20 (05) : 200
  • [35] Formulation Development and Characterization of Baclofen Floating Drug Delivery System
    Srinivasarao, Durga M.
    Saravanakumar, K.
    Bannoth, Chandrasekhar Kothapalli
    ASIAN JOURNAL OF PHARMACEUTICS, 2021, 15 (04) : 448 - 452
  • [36] FORMULATION DEVELOPMENT OF FLOATING DRUG DELIVERY SYSTEM (FDDS) FOR LAFUTIDINE
    Kiran, C. V. S. Raghu
    Gopinath, C.
    INDO AMERICAN JOURNAL OF PHARMACEUTICAL SCIENCES, 2015, 2 (06): : 1000 - 1006
  • [37] Domperidone resinate complex as new formulation for gastroretentive drug delivery
    Daihom, Baher A.
    Bendas, Ehab R.
    Mohamed, Magdy I.
    Badawi, Alia A.
    JOURNAL OF DRUG DELIVERY SCIENCE AND TECHNOLOGY, 2020, 58
  • [38] Formulation Optimization for Gastroretentive Drug Delivery System of Carvedilol Cocrystals Using Design of Experiment
    Fernandes, Gasper J.
    Rathnanand, Mahalaxmi
    JOURNAL OF PHARMACEUTICAL INNOVATION, 2020, 15 (03) : 455 - 466
  • [39] Bimodal Gastroretentive Drug Delivery Systems of Lamotrigine: Formulation and Evaluation
    Poonuru, R. R.
    Gonugunta, C. S. R.
    INDIAN JOURNAL OF PHARMACEUTICAL SCIENCES, 2014, 76 (06) : 476 - 482
  • [40] Optimization and characterization of gastroretentive floating drug delivery system using Box-Behnken design
    Rapolu, Kishore
    Sanka, Krishna
    Vemula, Praveen Kumar
    Aatipamula, Vinaydas
    Mohd, Abdul Bari
    Diwan, Prakash V.
    DRUG DEVELOPMENT AND INDUSTRIAL PHARMACY, 2013, 39 (12) : 1928 - 1935